ArticleOncotarget2018

PIK3CA and KRAS mutations in cell free circulating DNA are useful markers for monitoring ovarian clear cell carcinoma.

Asuka Morikawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.